1WCO image
Deposition Date 2004-11-19
Release Date 2005-03-07
Last Version Date 2024-05-01
Entry Detail
PDB ID:
1WCO
Title:
The solution structure of the nisin-lipid II complex
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Conformers Calculated:
200
Conformers Submitted:
20
Selection Criteria:
RMSD CLUSTERING AND LOWEST TOTAL ENERGY
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:ALA-FGA-LYS-DAL-DAL PEPTIDE
Chain IDs:A (auth: L)
Chain Length:5
Number of Molecules:1
Biological Source:MONARTHROPALPUS FLAVUS
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Lantibiotic
Chain IDs:B (auth: N)
Chain Length:34
Number of Molecules:1
Biological Source:Lactococcus lactis
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
DBU B THR modified residue
DHA B SER modified residue
Ligand Molecules
Peptide-like Molecules
PRD_000200
Primary Citation

Abstact

The emerging antibiotics-resistance problem has underlined the urgent need for novel antimicrobial agents. Lantibiotics (lanthionine-containing antibiotics) are promising candidates to alleviate this problem. Nisin, a member of this family, has a unique pore-forming activity against bacteria. It binds to lipid II, the essential precursor of cell wall synthesis. As a result, the membrane permeabilization activity of nisin is increased by three orders of magnitude. Here we report the solution structure of the complex of nisin and lipid II. The structure shows a novel lipid II-binding motif in which the pyrophosphate moiety of lipid II is primarily coordinated by the N-terminal backbone amides of nisin via intermolecular hydrogen bonds. This cage structure provides a rationale for the conservation of the lanthionine rings among several lipid II-binding lantibiotics. The structure of the pyrophosphate cage offers a template for structure-based design of novel antibiotics.

Legend

Protein

Chemical

Disease

Primary Citation of related structures